2023
DOI: 10.1016/j.rmed.2023.107376
|View full text |Cite
|
Sign up to set email alerts
|

Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Participants will be provided with several digital technologies to monitor different physiological parameters associated with asthma control and attacks (table 1). ► Digital inhaler or spacer 36 that records the time and date of inhaler use and inhaler technique for use ► Manual peak flow meter ► Resmonics nocturnal cough sensor 12 ► Smart watch-FitBit watch ► Study research app (custom-built for the study) ► Smartphone if the participant does not wish to use their own phone for data collection or if their smartphone is not compatible with the devices Participants will be able to track their progress through the mobile apps associated with the devices and view the data collected if they wish. If participants have any questions about their collected data or devices, they will be advised to contact the study team who will refer this to the lead investigator and study clinicians if the queries are clinical in nature.…”
Section: Digital Biomarkers Collected Prospectively By Smart Technolo...mentioning
confidence: 99%
“…Participants will be provided with several digital technologies to monitor different physiological parameters associated with asthma control and attacks (table 1). ► Digital inhaler or spacer 36 that records the time and date of inhaler use and inhaler technique for use ► Manual peak flow meter ► Resmonics nocturnal cough sensor 12 ► Smart watch-FitBit watch ► Study research app (custom-built for the study) ► Smartphone if the participant does not wish to use their own phone for data collection or if their smartphone is not compatible with the devices Participants will be able to track their progress through the mobile apps associated with the devices and view the data collected if they wish. If participants have any questions about their collected data or devices, they will be advised to contact the study team who will refer this to the lead investigator and study clinicians if the queries are clinical in nature.…”
Section: Digital Biomarkers Collected Prospectively By Smart Technolo...mentioning
confidence: 99%
“…The average adherence was 52%, higher than in the literature (around 35%), but it declined after the first 3 months of use. D ierick et al [ 69 ] (Groningen, the Netherlands) presented a smart spacer to monitor inhaler use and technique for patients with asthma. The device was evaluated in a 2-month randomised controlled feasibility trial in 42 asthma patients, resulting in a statistically significant reduction of inhaler errors by 26.2% while in the usual care group errors increased by 14.6%.…”
Section: Group 104: M-health/e-healthmentioning
confidence: 99%
“…Recent advances in eHealth technology exploit the potential of the "Internet of Things" to enhance digital medicine and therapeutics [13]. Novel respiratory technologies include connected spirometers, smart inhalers and spacers, tuberculosis treatment monitored by electronic pill bottles, clinical decision support that uses AI for radiological diagnosis, and digitally assisted home ventilation [14][15][16][17]. Digital health offers patients information, biofeedback, environmental data, access to diagnostics, support for medication adherence and self-management [18,19].…”
Section: Introductionmentioning
confidence: 99%